pmc-enju-pas Home  

PMC:3312845 / 6715-8147 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T3309 0-23 JJ denotes Intracerebroventricular
T3310 24-28 NN denotes drug
T3311 29-37 NN denotes infusion
T3312 38-42 NN denotes Rats
T3313 43-47 VB denotes were
T3314 48-55 VB denotes divided
T3315 56-60 IN denotes into
T3316 61-64 CD denotes two
T3317 65-71 NN denotes groups
T3318 71-72 -COLON- denotes :
T3319 73-80 NN denotes vehicle
T3320 81-82 -LRB- denotes (
T3321 82-88 NN denotes saline
T3322 88-89 -RRB- denotes )
T3323 89-97 JJ denotes -treated
T3324 98-101 CC denotes and
T3325 102-109 JJ denotes soluble
T3326 110-116 NN denotes TNFp55
T3327 117-125 NN denotes receptor
T3328 126-127 -LRB- denotes (
T3329 127-135 NN denotes sTNFp55R
T3330 135-136 -COMMA- denotes ,
T3331 137-139 CD denotes 50
T3332 140-145 NN denotes μg/ml
T3333 145-146 -COLON- denotes ;
T3334 147-160 NNP denotes Sigma-Aldrich
T3335 161-164 NNP denotes Co.
T3336 164-165 -COMMA- denotes ,
T3337 166-169 NNP denotes St.
T3338 170-175 NNP denotes Louis
T3339 175-176 -COMMA- denotes ,
T3340 177-179 NN denotes MO
T3341 179-180 -RRB- denotes )
T3342 180-188 JJ denotes -treated
T3343 189-195 NN denotes groups
T3344 197-200 DT denotes The
T3345 201-207 NN denotes dosage
T3346 208-210 IN denotes of
T3347 211-219 NN denotes sTNFp55R
T3348 220-223 VB denotes was
T3349 224-234 VB denotes determined
T3350 235-237 IN denotes as
T3351 238-241 DT denotes the
T3352 242-249 JJ denotes highest
T3353 250-254 NN denotes dose
T3354 255-259 WDT denotes that
T3355 260-267 VB denotes induced
T3356 268-270 NN denotes SE
T3357 271-273 IN denotes of
T3358 274-284 JJ denotes comparable
T3359 285-293 NN denotes severity
T3360 294-296 IN denotes in
T3361 297-300 CD denotes 100
T3362 300-301 NN denotes %
T3363 302-304 IN denotes of
T3364 305-312 NN denotes animals
T3365 313-317 IN denotes with
T3366 318-319 CD denotes 5
T3367 319-320 NN denotes %
T3368 321-330 NN denotes mortality
T3369 331-333 IN denotes in
T3370 334-337 DT denotes the
T3371 338-349 JJ denotes preliminary
T3372 350-355 NN denotes study
T3373 357-364 NN denotes Animals
T3374 365-369 VB denotes were
T3375 370-382 VB denotes anesthetized
T3376 383-384 -LRB- denotes (
T3377 384-392 NN denotes Zolretil
T3378 392-393 -COMMA- denotes ,
T3379 394-396 CD denotes 50
T3380 397-402 NN denotes mg/kg
T3381 402-403 -COMMA- denotes ,
T3382 404-408 NN denotes i.m.
T3383 408-409 -COLON- denotes ;
T3384 410-416 NNP denotes Virbac
T3385 417-429 NNP denotes Laboratories
T3386 429-430 -COMMA- denotes ,
T3387 431-437 NNP denotes France
T3388 437-438 -RRB- denotes )
T3389 439-442 CC denotes and
T3390 443-449 VB denotes placed
T3391 450-452 IN denotes in
T3392 453-454 DT denotes a
T3393 455-466 JJ denotes stereotaxic
T3394 467-473 NN denotes frames
T3395 475-478 IN denotes For
T3396 479-482 DT denotes the
T3397 483-490 JJ denotes osmotic
T3398 491-495 NN denotes pump
T3399 496-508 NN denotes implantation
T3400 508-509 -COMMA- denotes ,
T3401 510-515 NN denotes holes
T3402 516-520 VB denotes were
T3403 521-528 VB denotes drilled
T3404 529-536 IN denotes through
T3405 537-540 DT denotes the
T3406 541-546 NN denotes skull
T3407 547-549 TO denotes to
T3408 550-559 VB denotes introduce
T3409 560-561 DT denotes a
T3410 562-567 NN denotes brain
T3411 568-576 NN denotes infusion
T3412 577-580 NN denotes kit
T3413 581-582 CD denotes 1
T3414 583-584 -LRB- denotes (
T3415 584-589 NNP denotes Alzet
T3416 589-590 -COMMA- denotes ,
T3417 591-600 NNP denotes Cupertino
T3418 600-601 -COMMA- denotes ,
T3419 602-604 NN denotes CA
T3420 604-605 -RRB- denotes )
T3421 606-610 IN denotes into
T3422 611-614 DT denotes the
T3423 615-620 JJ denotes right
T3424 621-628 JJ denotes lateral
T3425 629-638 NN denotes ventricle
T3426 639-640 -LRB- denotes (
T3427 640-641 CD denotes 1
T3428 642-644 NN denotes mm
T3429 645-654 JJ denotes posterior
T3430 654-655 -COLON- denotes ;
T3431 656-659 CD denotes 1.5
T3432 660-662 NN denotes mm
T3433 663-670 JJ denotes lateral
T3434 670-671 -COLON- denotes ;
T3435 672-673 -COLON- denotes -
T3436 674-677 CD denotes 3.5
T3437 678-680 NN denotes mm
T3438 681-686 NN denotes depth
T3439 686-687 -COLON- denotes ;
T3440 688-692 JJ denotes flat
T3441 693-698 NN denotes skull
T3442 699-707 NN denotes position
T3443 708-712 IN denotes with
T3444 713-719 NN denotes bregma
T3445 720-722 IN denotes as
T3446 723-732 NN denotes reference
T3447 732-733 -RRB- denotes )
T3448 733-734 -COMMA- denotes ,
T3449 735-744 VB denotes according
T3450 745-747 TO denotes to
T3451 748-751 DT denotes the
T3452 752-757 NN denotes atlas
T3453 758-760 IN denotes of
T3454 761-768 NNP denotes Paxinos
T3455 769-772 CC denotes and
T3456 773-779 NNP denotes Watson
T3457 780-781 -LRB- denotes [
T3458 781-783 CD denotes 24
T3459 783-784 -RRB- denotes ]
T3460 786-789 DT denotes The
T3461 790-798 NN denotes infusion
T3462 799-802 NN denotes kit
T3463 803-806 VB denotes was
T3464 807-813 VB denotes sealed
T3465 814-818 IN denotes with
T3466 819-825 JJ denotes dental
T3467 826-832 NN denotes cement
T3468 833-836 CC denotes and
T3469 837-846 VB denotes connected
T3470 847-849 TO denotes to
T3471 850-852 DT denotes an
T3472 853-860 JJ denotes osmotic
T3473 861-865 NN denotes pump
T3474 866-867 -LRB- denotes (
T3475 867-872 NN denotes 1007D
T3476 872-873 -COMMA- denotes ,
T3477 874-879 NNP denotes Alzet
T3478 879-880 -COMMA- denotes ,
T3479 881-890 NNP denotes Cupertino
T3480 890-891 -COMMA- denotes ,
T3481 892-894 NNP denotes CA
T3482 894-895 -RRB- denotes )
T3483 897-900 DT denotes The
T3484 901-905 NN denotes pump
T3485 906-909 VB denotes was
T3486 910-916 VB denotes placed
T3487 917-919 IN denotes in
T3488 920-921 DT denotes a
T3489 922-934 JJ denotes subcutaneous
T3490 935-941 NN denotes pocket
T3491 942-944 IN denotes in
T3492 945-948 DT denotes the
T3493 949-955 JJ denotes dorsal
T3494 956-962 NN denotes region
T3495 964-971 NN denotes Animals
T3496 972-980 VB denotes received
T3497 981-984 CD denotes 0.5
T3498 985-990 NN denotes μl/hr
T3499 991-993 IN denotes of
T3500 994-1001 NN denotes vehicle
T3501 1002-1004 CC denotes or
T3502 1005-1013 NN denotes compound
T3503 1014-1017 IN denotes for
T3504 1018-1019 CD denotes 1
T3505 1020-1024 NN denotes week
T3506 1026-1035 RB denotes Therefore
T3507 1035-1036 -COMMA- denotes ,
T3508 1037-1040 DT denotes the
T3509 1041-1045 NN denotes dose
T3510 1046-1048 IN denotes of
T3511 1049-1057 NN denotes sTNFp55R
T3512 1058-1061 VB denotes was
T3513 1062-1065 CD denotes 0.6
T3514 1066-1072 NN denotes μg/day
T3515 1073-1076 IN denotes per
T3516 1077-1081 DT denotes each
T3517 1082-1088 NN denotes animal
T3518 1090-1093 DT denotes The
T3519 1094-1103 NN denotes compounds
T3520 1104-1109 VB denotes began
T3521 1110-1112 TO denotes to
T3522 1113-1115 VB denotes be
T3523 1116-1127 RB denotes immediately
T3524 1128-1135 VB denotes infused
T3525 1136-1141 IN denotes after
T3526 1142-1149 NN denotes surgery
T3527 1151-1156 IN denotes Since
T3528 1157-1160 DT denotes the
T3529 1161-1167 NN denotes volume
T3530 1168-1170 IN denotes of
T3531 1171-1180 JJ denotes vasogenic
T3532 1181-1186 NN denotes edema
T3533 1187-1193 VB denotes peaked
T3534 1194-1196 IN denotes at
T3535 1197-1200 CD denotes 2-3
T3536 1201-1205 NN denotes days
T3537 1206-1211 IN denotes after
T3538 1212-1214 NN denotes SE
T3539 1215-1217 IN denotes in
T3540 1218-1221 PRP-DOLLAR- denotes our
T3541 1222-1230 JJ denotes previous
T3542 1231-1238 NN denotes studies
T3543 1239-1240 -LRB- denotes [
T3544 1240-1246 CD denotes 5-8,20
T3545 1246-1247 -RRB- denotes ]
T3546 1247-1248 -COMMA- denotes ,
T3547 1249-1251 PRP denotes we
T3548 1252-1257 VB denotes chose
T3549 1258-1262 DT denotes this
T3550 1263-1267 NN denotes time
T3551 1268-1273 NN denotes point
T3552 1275-1279 RB denotes Thus
T3553 1279-1280 -COMMA- denotes ,
T3554 1281-1284 PRP-DOLLAR- denotes our
T3555 1285-1297 JJ denotes experimental
T3556 1298-1307 NN denotes schedules
T3557 1308-1310 IN denotes at
T3558 1311-1316 JJ denotes least
T3559 1317-1324 VB denotes inhibit
T3560 1325-1328 DT denotes the
T3561 1329-1337 NN denotes function
T3562 1338-1340 IN denotes of
T3563 1341-1346 NN denotes TNF-α
T3564 1347-1351 IN denotes from
T3565 1352-1353 CD denotes 3
T3566 1354-1358 NN denotes days
T3567 1359-1364 RB denotes prior
T3568 1365-1367 TO denotes to
T3569 1368-1370 VB denotes SE
T3570 1371-1373 TO denotes to
T3571 1374-1375 CD denotes 4
T3572 1376-1380 NN denotes days
T3573 1381-1386 IN denotes after
T3574 1387-1389 NN denotes SE
T3575 1390-1394 WRB denotes when
T3576 1395-1398 DT denotes the
T3577 1399-1405 NN denotes volume
T3578 1406-1408 IN denotes of
T3579 1409-1418 JJ denotes vasogenic
T3580 1419-1424 NN denotes edema
T3581 1425-1431 VB denotes peaked
R2454 T3311 T3309 arg1Of infusion,Intracerebroventricular
R2455 T3311 T3310 arg1Of infusion,drug
R2456 T3312 T3313 arg1Of Rats,were
R2457 T3312 T3314 arg2Of Rats,divided
R2458 T3314 T3313 arg2Of divided,were
R2459 T3314 T3315 arg1Of divided,into
R2460 T3314 T3343 arg1Of divided,groups
R2461 T3317 T3315 arg2Of groups,into
R2462 T3317 T3316 arg1Of groups,two
R2463 T3317 T3318 arg1Of groups,:
R2464 T3321 T3320 arg2Of saline,(
R2465 T3322 T3320 arg3Of ),(
R2466 T3323 T3324 arg1Of -treated,and
R2467 T3325 T3324 arg2Of soluble,and
R2468 T3327 T3318 arg2Of receptor,:
R2469 T3327 T3319 arg1Of receptor,vehicle
R2470 T3327 T3320 arg1Of receptor,(
R2471 T3327 T3323 arg1Of receptor,-treated
R2472 T3327 T3325 arg1Of receptor,soluble
R2473 T3327 T3326 arg1Of receptor,TNFp55
R2474 T3327 T3328 arg1Of receptor,(
R2475 T3329 T3328 arg2Of sTNFp55R,(
R2476 T3329 T3330 arg1Of sTNFp55R,","
R2477 T3329 T3333 arg1Of sTNFp55R,;
R2478 T3332 T3330 arg2Of μg/ml,","
R2479 T3332 T3331 arg1Of μg/ml,50
R2480 T3335 T3333 arg2Of Co.,;
R2481 T3335 T3334 arg1Of Co.,Sigma-Aldrich
R2482 T3335 T3336 arg1Of Co.,","
R2483 T3338 T3336 arg2Of Louis,","
R2484 T3338 T3337 arg1Of Louis,St.
R2485 T3338 T3339 arg1Of Louis,","
R2486 T3340 T3339 arg2Of MO,","
R2487 T3341 T3328 arg3Of ),(
R2488 T3343 T3342 arg1Of groups,-treated
R2489 T3345 T3344 arg1Of dosage,The
R2490 T3345 T3346 arg1Of dosage,of
R2491 T3345 T3348 arg1Of dosage,was
R2492 T3345 T3349 arg2Of dosage,determined
R2493 T3347 T3346 arg2Of sTNFp55R,of
R2494 T3349 T3348 arg2Of determined,was
R2495 T3349 T3350 arg1Of determined,as
R2496 T3353 T3350 arg2Of dose,as
R2497 T3353 T3351 arg1Of dose,the
R2498 T3353 T3352 arg1Of dose,highest
R2499 T3353 T3354 arg1Of dose,that
R2500 T3353 T3355 arg1Of dose,induced
R2501 T3356 T3355 arg2Of SE,induced
R2502 T3356 T3357 arg1Of SE,of
R2503 T3359 T3357 arg2Of severity,of
R2504 T3359 T3358 arg1Of severity,comparable
R2505 T3359 T3360 arg1Of severity,in
R2506 T3362 T3360 arg2Of %,in
R2507 T3362 T3361 arg1Of %,100
R2508 T3362 T3363 arg1Of %,of
R2509 T3362 T3365 arg1Of %,with
R2510 T3364 T3363 arg2Of animals,of
R2511 T3366 T3367 arg1Of 5,%
R2512 T3368 T3365 arg2Of mortality,with
R2513 T3368 T3366 arg1Of mortality,5
R2514 T3368 T3369 arg1Of mortality,in
R2515 T3372 T3369 arg2Of study,in
R2516 T3372 T3370 arg1Of study,the
R2517 T3372 T3371 arg1Of study,preliminary
R2518 T3373 T3374 arg1Of Animals,were
R2519 T3373 T3375 arg2Of Animals,anesthetized
R2520 T3373 T3390 arg2Of Animals,placed
R2521 T3375 T3376 arg1Of anesthetized,(
R2522 T3375 T3389 arg1Of anesthetized,and
R2523 T3377 T3378 arg1Of Zolretil,","
R2524 T3377 T3381 arg1Of Zolretil,","
R2525 T3377 T3383 arg1Of Zolretil,;
R2526 T3380 T3378 arg2Of mg/kg,","
R2527 T3380 T3379 arg1Of mg/kg,50
R2528 T3382 T3381 arg2Of i.m.,","
R2529 T3383 T3376 arg2Of ;,(
R2530 T3385 T3383 arg2Of Laboratories,;
R2531 T3385 T3384 arg1Of Laboratories,Virbac
R2532 T3385 T3386 arg1Of Laboratories,","
R2533 T3387 T3386 arg2Of France,","
R2534 T3388 T3376 arg3Of ),(
R2535 T3389 T3374 arg2Of and,were
R2536 T3390 T3389 arg2Of placed,and
R2537 T3390 T3391 arg1Of placed,in
R2538 T3394 T3391 arg2Of frames,in
R2539 T3394 T3392 arg1Of frames,a
R2540 T3394 T3393 arg1Of frames,stereotaxic
R2541 T3399 T3395 arg2Of implantation,For
R2542 T3399 T3396 arg1Of implantation,the
R2543 T3399 T3397 arg1Of implantation,osmotic
R2544 T3399 T3398 arg1Of implantation,pump
R2545 T3401 T3402 arg1Of holes,were
R2546 T3401 T3403 arg2Of holes,drilled
R2547 T3403 T3395 arg1Of drilled,For
R2548 T3403 T3400 arg1Of drilled,","
R2549 T3403 T3402 arg2Of drilled,were
R2550 T3403 T3404 arg1Of drilled,through
R2551 T3403 T3414 arg1Of drilled,(
R2552 T3403 T3421 arg1Of drilled,into
R2553 T3403 T3448 arg1Of drilled,","
R2554 T3403 T3449 arg1Of drilled,according
R2555 T3406 T3404 arg2Of skull,through
R2556 T3406 T3405 arg1Of skull,the
R2557 T3406 T3407 modOf skull,to
R2558 T3408 T3407 arg1Of introduce,to
R2559 T3412 T3408 arg2Of kit,introduce
R2560 T3412 T3409 arg1Of kit,a
R2561 T3412 T3410 arg1Of kit,brain
R2562 T3412 T3411 arg1Of kit,infusion
R2563 T3412 T3413 arg1Of kit,1
R2564 T3415 T3416 arg1Of Alzet,","
R2565 T3416 T3414 arg2Of ",",(
R2566 T3416 T3418 arg1Of ",",","
R2567 T3417 T3416 arg2Of Cupertino,","
R2568 T3419 T3418 arg2Of CA,","
R2569 T3420 T3414 arg3Of ),(
R2570 T3425 T3421 arg2Of ventricle,into
R2571 T3425 T3422 arg1Of ventricle,the
R2572 T3425 T3423 arg1Of ventricle,right
R2573 T3425 T3424 arg1Of ventricle,lateral
R2574 T3425 T3426 arg1Of ventricle,(
R2575 T3428 T3427 arg1Of mm,1
R2576 T3428 T3429 arg1Of mm,posterior
R2577 T3428 T3430 arg1Of mm,;
R2578 T3430 T3426 arg2Of ;,(
R2579 T3430 T3439 arg1Of ;,;
R2580 T3431 T3432 arg1Of 1.5,mm
R2581 T3432 T3433 arg1Of mm,lateral
R2582 T3432 T3436 arg1Of mm,3.5
R2583 T3433 T3434 arg1Of lateral,;
R2584 T3433 T3435 arg1Of lateral,-
R2585 T3436 T3435 arg2Of 3.5,-
R2586 T3436 T3437 arg1Of 3.5,mm
R2587 T3438 T3430 arg2Of depth,;
R2588 T3438 T3431 arg1Of depth,1.5
R2589 T3442 T3439 arg2Of position,;
R2590 T3442 T3440 arg1Of position,flat
R2591 T3442 T3441 arg1Of position,skull
R2592 T3442 T3443 arg1Of position,with
R2593 T3442 T3445 arg1Of position,as
R2594 T3444 T3443 arg2Of bregma,with
R2595 T3446 T3445 arg2Of reference,as
R2596 T3447 T3426 arg3Of ),(
R2597 T3450 T3449 arg2Of to,according
R2598 T3452 T3450 arg2Of atlas,to
R2599 T3452 T3451 arg1Of atlas,the
R2600 T3452 T3453 arg1Of atlas,of
R2601 T3454 T3455 arg1Of Paxinos,and
R2602 T3455 T3453 arg2Of and,of
R2603 T3456 T3455 arg2Of Watson,and
R2604 T3456 T3457 arg1Of Watson,[
R2605 T3458 T3457 arg2Of 24,[
R2606 T3459 T3457 arg3Of ],[
R2607 T3462 T3460 arg1Of kit,The
R2608 T3462 T3461 arg1Of kit,infusion
R2609 T3462 T3463 arg1Of kit,was
R2610 T3462 T3464 arg2Of kit,sealed
R2611 T3462 T3469 arg2Of kit,connected
R2612 T3464 T3465 arg1Of sealed,with
R2613 T3464 T3468 arg1Of sealed,and
R2614 T3467 T3465 arg2Of cement,with
R2615 T3467 T3466 arg1Of cement,dental
R2616 T3468 T3463 arg2Of and,was
R2617 T3469 T3468 arg2Of connected,and
R2618 T3469 T3470 arg1Of connected,to
R2619 T3473 T3470 arg2Of pump,to
R2620 T3473 T3471 arg1Of pump,an
R2621 T3473 T3472 arg1Of pump,osmotic
R2622 T3473 T3474 arg1Of pump,(
R2623 T3475 T3474 arg2Of 1007D,(
R2624 T3475 T3476 arg1Of 1007D,","
R2625 T3475 T3480 arg1Of 1007D,","
R2626 T3477 T3476 arg2Of Alzet,","
R2627 T3477 T3478 arg1Of Alzet,","
R2628 T3479 T3478 arg2Of Cupertino,","
R2629 T3481 T3480 arg2Of CA,","
R2630 T3482 T3474 arg3Of ),(
R2631 T3484 T3483 arg1Of pump,The
R2632 T3484 T3485 arg1Of pump,was
R2633 T3484 T3486 arg2Of pump,placed
R2634 T3486 T3485 arg2Of placed,was
R2635 T3486 T3487 arg1Of placed,in
R2636 T3490 T3487 arg2Of pocket,in
R2637 T3490 T3488 arg1Of pocket,a
R2638 T3490 T3489 arg1Of pocket,subcutaneous
R2639 T3490 T3491 arg1Of pocket,in
R2640 T3494 T3491 arg2Of region,in
R2641 T3494 T3492 arg1Of region,the
R2642 T3494 T3493 arg1Of region,dorsal
R2643 T3495 T3496 arg1Of Animals,received
R2644 T3496 T3503 arg1Of received,for
R2645 T3498 T3496 arg2Of μl/hr,received
R2646 T3498 T3497 arg1Of μl/hr,0.5
R2647 T3498 T3499 arg1Of μl/hr,of
R2648 T3500 T3501 arg1Of vehicle,or
R2649 T3501 T3499 arg2Of or,of
R2650 T3502 T3501 arg2Of compound,or
R2651 T3505 T3503 arg2Of week,for
R2652 T3505 T3504 arg1Of week,1
R2653 T3509 T3508 arg1Of dose,the
R2654 T3509 T3510 arg1Of dose,of
R2655 T3509 T3512 arg1Of dose,was
R2656 T3511 T3510 arg2Of sTNFp55R,of
R2657 T3512 T3506 arg1Of was,Therefore
R2658 T3512 T3507 arg1Of was,","
R2659 T3514 T3512 arg2Of μg/day,was
R2660 T3514 T3513 arg1Of μg/day,0.6
R2661 T3514 T3515 arg1Of μg/day,per
R2662 T3517 T3515 arg2Of animal,per
R2663 T3517 T3516 arg1Of animal,each
R2664 T3519 T3518 arg1Of compounds,The
R2665 T3519 T3520 arg1Of compounds,began
R2666 T3519 T3522 arg1Of compounds,be
R2667 T3519 T3524 arg2Of compounds,infused
R2668 T3524 T3520 arg2Of infused,began
R2669 T3524 T3521 arg1Of infused,to
R2670 T3524 T3522 arg2Of infused,be
R2671 T3524 T3523 arg1Of infused,immediately
R2672 T3524 T3525 arg1Of infused,after
R2673 T3526 T3525 arg2Of surgery,after
R2674 T3529 T3528 arg1Of volume,the
R2675 T3529 T3530 arg1Of volume,of
R2676 T3529 T3533 arg1Of volume,peaked
R2677 T3532 T3530 arg2Of edema,of
R2678 T3532 T3531 arg1Of edema,vasogenic
R2679 T3533 T3527 arg2Of peaked,Since
R2680 T3533 T3534 arg1Of peaked,at
R2681 T3533 T3537 arg1Of peaked,after
R2682 T3536 T3534 arg2Of days,at
R2683 T3536 T3535 arg1Of days,2-3
R2684 T3538 T3537 arg2Of SE,after
R2685 T3538 T3539 arg1Of SE,in
R2686 T3542 T3539 arg2Of studies,in
R2687 T3542 T3540 arg1Of studies,our
R2688 T3542 T3541 arg1Of studies,previous
R2689 T3542 T3543 arg1Of studies,[
R2690 T3544 T3543 arg2Of "5-8,20",[
R2691 T3545 T3543 arg3Of ],[
R2692 T3547 T3548 arg1Of we,chose
R2693 T3548 T3527 arg1Of chose,Since
R2694 T3548 T3546 arg1Of chose,","
R2695 T3551 T3548 arg2Of point,chose
R2696 T3551 T3549 arg1Of point,this
R2697 T3551 T3550 arg1Of point,time
R2698 T3556 T3554 arg1Of schedules,our
R2699 T3556 T3555 arg1Of schedules,experimental
R2700 T3556 T3559 arg1Of schedules,inhibit
R2701 T3556 T3569 arg1Of schedules,SE
R2702 T3558 T3557 arg1Of least,at
R2703 T3559 T3552 arg1Of inhibit,Thus
R2704 T3559 T3553 arg1Of inhibit,","
R2705 T3559 T3558 arg1Of inhibit,least
R2706 T3559 T3567 arg1Of inhibit,prior
R2707 T3559 T3568 modOf inhibit,to
R2708 T3561 T3559 arg2Of function,inhibit
R2709 T3561 T3560 arg1Of function,the
R2710 T3561 T3562 arg1Of function,of
R2711 T3561 T3564 arg1Of function,from
R2712 T3563 T3562 arg2Of TNF-α,of
R2713 T3566 T3564 arg2Of days,from
R2714 T3566 T3565 arg1Of days,3
R2715 T3569 T3568 arg1Of SE,to
R2716 T3569 T3570 arg1Of SE,to
R2717 T3569 T3573 arg1Of SE,after
R2718 T3569 T3575 arg1Of SE,when
R2719 T3571 T3570 arg2Of 4,to
R2720 T3573 T3572 arg1Of after,days
R2721 T3574 T3573 arg2Of SE,after
R2722 T3577 T3576 arg1Of volume,the
R2723 T3577 T3578 arg1Of volume,of
R2724 T3577 T3581 arg1Of volume,peaked
R2725 T3580 T3578 arg2Of edema,of
R2726 T3580 T3579 arg1Of edema,vasogenic
R2727 T3581 T3575 arg2Of peaked,when